Sunil Healthcare credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY24Mar 2024

	66.2
	62.6
	0.89×
	0.84×
	16.18×
	15.31×
	−0.35×
	47.2%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SUNLOC₹61.00

Sunil Healthcare Limited

· Pharma & Health

₹ CrorePeersBPLPHARMA JENBURPH KPL MAKERSL NOVARTIND PARNAXLAB SGRL SHUKRAPHARMcap ₹62.7 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

	Ratios — % unless marked × 12 Months Ending	FY24 31/03/2024
	Total Debt	66.2
	Net Debt	62.6
	Total Debt/Equity	0.89
	Net Debt/Equity	0.84
	Total Debt/EBITDA	16.18
	Net Debt/EBITDA	15.31
	Interest Coverage (EBIT/Interest)	-0.35
	Total Debt/Total Capital %	47.19

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.